ADMA Biologics (ADMA) Stock Highlights

19.32 | +3.26%

2024-09-19 01:15:42

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. Its targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disorder or who may be immune-suppressed for medical reasons. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services.

Statistics

Range Today

18.69 19.75

Volume Today 6.95M

Range 1 Year

3.06 19.34

Volume 1 Year 700.98M

Range 3 Year

1.01 19.34

Volume 3 Year 1.98B

Range 10 Year

1.01 19.34

Volume 10 Year 4.04B

Highlights

Market Capitalization 4.22B (mid)

Floating Shares 228.85M

Current Price 19.32

Price To Earnings 127.5

Price To Revenue 12.93

Price To Book 22.39

Earnings Per Share 0.14

Payout Ratio 0%

Performance

Latest +3.26%

1 Month +9.71%

3 Months +85.23%

6 Months +220.4%

1 Year +416.58%

3 Years +1470.73%

5 Years +268%

10 Years +96.14%

Benchmarks

Market Capitalization

112 / 368

Gross Profits

70 / 278

Total Revenue

50 / 300

Total Rank

222 / 368

Free Cashflow

126 / 352

Performance 5 years

33 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.